In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

In 2025, cannabis faces major changes with federal reclassification, easing regulations, increasing research, and opening ...

An alleged leader from Japan’s Yakuza crime syndicate has pleaded guilty to trafficking nuclear materials from Myanmar as ...

Mafia leader caught in sting operation trying to sell weapons-grade nuclear material to man he believed was Iranian general ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

The Drug Enforcement Administration (DEA) is facing criticism after failing to release updated annual data on ...

As a chronic pain patient, I have experienced the anguish and degradation of being denied pain medication firsthand,” a STAT reader writes.

The Merit Systems Protection Board needs to examine if the US government incorrectly denied a DEA agent a promotion for more ...